International Human Microbiome Coordination and Support Action

Risultati finali

Ethical and policy issues in microbiome research and symbiosis monitoring

D7.1 Ethical and policy issues in microbiome research and symbiosis monitoring (M24)Report on evidence-based tools for microbiome-oriented self-care and medical decisions aids based on international standards on metagenomics data production and validation, resulting in a Mutual learning protocol to empower early-stage researchers to explore and address ethical and policy issues in microbiome research. EUR

White paper and recommendations on the human microbiome addressing gaps, emerging fields and political priorities

D4.3 White paper and recommendations on the human microbiome addressing gaps, emerging fields and political priorities, UCC (M36)

Recommendations for responsible research and innovation rules in the field of microbiome

D7.3 Recommendations for responsible research and innovation rules in the field of microbiome EUR (M36)

Report proposing initiatives for unified repositories for processed data

D3.2 Report proposing initiatives for unified repositories for processed data, UNITN (M30)

Consensus opinion paper (submission) on new approaches for intervention studies

D5.3 Consensus opinion paper (submission) on new approaches for intervention studies. UP (M30).

Policies and regulations for self-management tools

D7.2 Policies and regulations for self-management tools. PRI (M36)1) Report on the different policies needed in order to ensure appropriate regulation and control of ethical issues surrounding self-management tools, and 2) Report on the adaptation of ICH and EMA guidelines on pharmacogenomic biomarkers to microbiome-specific aspects and recommendation to the EMA

Report on the Delphi consultation: Questionnaire & analysis of the. consultation answers

D5.1 Report on the Delphi consultation: Questionnaire & analysis of the. consultation answers

Consensus opinion paper (submission) on preclinical models for microbiome research with focus on causality

D5.2 Consensus opinion paper (submission) on preclinical models for microbiome research with focus on causality

Report on clinical endpoints metadata

D1.2 Report on clinical endpoints metadata, EF-CLIF (M36)

Sustainability plan including toolbox

D8.2 Sustainability plan including toolbox (EUFIC, M30)

Communication and dissemination plan

D81 Communication and dissemination plan EUFIC M6

Report on interoperability

D2.2 Report on interoperability, INRAE (M36)

Report on the highlights of communication and dissemination efforts with KPI indicators

D8.3 Report on the highlights of communication and dissemination efforts with KPI indicators (EUFIC, M36)

Report on human microbiome data

D2.1 Report on human microbiome data, UCPH (M24)

Report on recommendations for microbiome analysis standards

D3.1 Report on recommendations for microbiome analysis standards, UCPH (M30)

Roadmap proposal for a European Microbiome-Dedicated Surveillance Network

D7.4 Roadmap proposal for a European Microbiome-Dedicated Surveillance Network EUR (M36)

Position paper (submission) on biomarker identification, preanalytical & analytical validation

D6.2 Position paper (submission) on biomarker identification, preanalytical & analytical validation. LNS (M30)

Pubblicazioni

Editorial: Acute-on-chronic liver failure: systemic inflammation and immunosuppression.

Autori: Tyc O, Shi Y, Fan YC, Trebicka J, Xiang X
Pubblicato in: Frontiers in Immunology, Numero 2023 Aug 15, 2023, ISSN 1664-3224
Editore: Frontiers Media
DOI: 10.3389/fimmu.2023.1260749

Targeted decrease of portal hepatic pressure gradient improves ascites control after TIPS

Autori: Alexander Queck, Louise Schwierz, Wenyi Gu, Philip G. Ferstl, Christian Jansen, Frank E. Uschner, Michael Praktiknjo, Johannes Chang, Maximilian J. Brol, Filippo Schepis, Manuela Merli, Christian P. Strassburg, Jennifer Lehmann, Carsten Meyer, Jonel Trebicka
Pubblicato in: Hepatology, 2022, ISSN 0270-9139
Editore: John Wiley & Sons Inc.
DOI: 10.1002/hep.32676

"""Human-microbes symbiosis inhealth and disease, on earth andbeyond planetary boundaries"""

Autori: Dore J & Ortega-Ugalde S
Pubblicato in: Frontiers in Astronomy and Space Sciences, Numero 2023 Sept, 2023, ISSN 2296-987X
Editore: Frontiers Media
DOI: 10.3389/fspas.2023.1180522

Editorial: Portal Hypertension in Cirrhosis: From Pathogenesis to Novel Treatments

Autori: Chandana B. Herath, Peter W. Angus, and Jonel Trebicka
Pubblicato in: Frontiers in Physiology, 2022, ISSN 1664-042X
Editore: Frontiers Research Foundation
DOI: 10.3389/fphys.2022.864083

Stage of fibrosis is not a predictive determinant of weight loss in patients undergoing bariatric surgery

Autori: Brol MJ, Drebber U, Yu X, Schierwagen R, Gu W, Plamper A, Klein S, Odenthal M, Uschner FE, Praktiknjo M, Trebicka J, Rheinwalt KP
Pubblicato in: Surgery for Obesity and Related Diseases, Numero 2024, 2024, ISSN 1550-7289
Editore: Elsevier BV
DOI: 10.1016/j.soard.2024.02.006

Recent advances in the prevention and treatment of decompensated cirrhosis and acute-on-chronic liver failure (ACLF) and the role of biomarkers

Autori: Trebicka J, Hernaez R, Shawcross DL, Gerbes AL
Pubblicato in: Gut, Numero 2024 Mar 25, 2024, ISSN 0017-5749
Editore: BMJ Publishing Group
DOI: 10.1136/gutjnl-2023-330584

Blood Endotoxin Levels as Biomarker of Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-analysis

Autori: Soppert, Josefin; Brandt, Elisa Fabiana; Heussen, Nicole Maria; Barzakova, Emona; Blank, Lars M.; Küpfer, Lars; Hornef, Mathias; Trebicka, Jonel; Jankowski, Joachim; Berres, Marie-Luise; Noels, Heidi
Pubblicato in: Clinical Gastroenterology and Hepatology, Numero 7, 2023, Pagina/e 2746-2758, ISSN 1542-3565
Editore: W. B. Saunders Co., Ltd.
DOI: 10.1016/j.cgh.2022.11.030

Pathogenetic mechanisms and therapeutic approaches of acute-to-chronic liver failure

Autori: Schierwagen, Robert; Gu, Wenyi; Brieger, Angela; Brüne, Bernhard; Ciesek, Sandra; Đikić, Ivan; Dimmeler, Stefanie; Geisslinger, Gerd; Greten, Florian R.; Hermann, Eva; Hildt, Eberhard; Kempf, Volkhard A. J.; Klein, Sabine; Koch, Ina; Mühl, Heiko; Müller, Volker; Peiffer, Kai-Henrik; Kestner, Roxane-Isabelle; Piiper, Albrecht; Rohde, Gernot; Scholich, Klaus; Schulz, Marcel H.; Storf, Holger; T
Pubblicato in: American journal of physiology. Cell physiology, Numero 8, 2023, ISSN 0363-6143
Editore: American Physiological Society
DOI: 10.1152/ajpcell.00101.2023

Atorvastatin for patients with cirrhosis. A randomized, placebo-controlled trial.

Autori: Kronborg TM, Schierwagen R, Trošt K, Gao Q, Moritz T, Bendtsen F, Gantzel RH, Andersen ML, Teisner AS, Grønbæk H, Hobolth L, Møller S, Trebicka J, Kimer N
Pubblicato in: Hepatology Communications, Numero 2023 Dec 1, 2023, ISSN 2471-254x
Editore: Wolters Kluwer Health
DOI: 10.1097/hc9.0000000000000332

The Role of Hypoxia-Inducible Factor 1 Alpha in Acute-on-Chronic Liver Failure.

Autori: Mücke MM, El Bali N, Schwarzkopf KM, Uschner FE, Kraus N, Eberle L, Mücke VT, Bein J, Beyer S, Wild PJ, Schierwagen R, Klein S, Zeuzem S, Welsch C, Trebicka J, Brieger A
Pubblicato in: International Journal of Molecular Sciences, Numero 2024 Jan 26, 2024, ISSN 1422-0067
Editore: Multidisciplinary Digital Publishing Institute (MDPI)
DOI: 10.3390/ijms25031542

The rationale and study design of two phase II trials examining the effects of BI 685509, a soluble guanylyl cyclase activator, on clinically significant portal hypertension in patients with compensated cirrhosis

Autori: Reiberger, Thomas; Berzigotti, Annalisa; Trebicka, Jonel; Ertle, Judith; Gashaw, Isabella; Swallow, Ros; Tomisser, Andrea
Pubblicato in: Trials, Numero 10, 2023, ISSN 1745-6215
Editore: BioMed Central
DOI: 10.1186/s13063-023-07291-3

Acute-On-Chronic Liver Failure: Current Interventional Treatment Options and Future Challenges

Autori: Markus Kimmann; Jonel Trebicka
Pubblicato in: Journal of Personalized Medicine, Vol 13, Iss 7, p 1052 (2023), Numero 11, 2023, ISSN 2075-4426
Editore: MDPI
DOI: 10.3390/jpm13071052

Use and outcome of TIPS in hospitalized patients in Germany: A Nationwide study (2007-2018).

Autori: Gu W, Zeleke Y, Hortlik H, Schaaf L, Uschner FE, Schulz M, Tischendorf M, Peiffer KH, Brol MJ, Kimmann M, Vogl T, Köhler M, Meyer C, Gerbes A, Rössle M, Laleman W, Zipprich A, Steib C, Praktiknjo M, Trebicka J; German TIPS Working Group.
Pubblicato in: Hepatology Communications, Numero 2023 Sep 15, 2023, ISSN 2471-254x
Editore: Wolters Kluwer Health
DOI: 10.1097/hc9.0000000000000237

Janus kinase 2 inhibition by pacritinib as potential therapeutic target for liver fibrosis

Autori: Sandra Torres; Cristina Ortiz; Nadine Bachtler; Wenyi Gu; Leon D. Grünewald; Nico Kraus; Robert Schierwagen; Christoph Hieber; Caroline Meier; Olaf Tyc; Maximilian Joseph Brol; Frank Erhard Uschner; Bart Nijmeijer; Christoph Welsch; Marie‐Luise Berres; Carmen Garcia‐Ruiz; Jose Carlos Fernandez‐Checa; Christian Trautwein; Thomas J. Vogl; Stefan Zeuzem; Jonel Trebicka; Sabine Klein
Pubblicato in: Hepatology, 2022, ISSN 0270-9139
Editore: John Wiley & Sons Inc.
DOI: 10.1002/hep.32746

Sympathetic nervous activation, mitochondrial dysfunction and outcome in acutely decompensated cirrhosis: the metabolomic prognostic models (CLIF-C MET)

Autori: Emmanuel Weiss; Carlos de la Peña-Ramirez; Ferran Aguilar; Juan-Jose Lozano; Cristina Sánchez-Garrido; Patricia Sierra; Pedro Izquierdo-Bueno Martin; Juan Manuel Diaz; François Fenaille; Florence A Castelli; Thierry Gustot; Wim Laleman; Agustín Albillos; Carlo Alessandria; Marco Domenicali; Paolo Caraceni; Salvatore Piano; Faouzi Saliba; Stefan Zeuzem; Alexander L Gerbes; Julia A Wendon; Chris
Pubblicato in: Gut, Numero 6, 2023, Pagina/e 1581-1591, ISSN 0017-5749
Editore: BMJ Publishing Group
DOI: 10.1136/gutjnl-2022-328708

Epidemiology of liver transplantation and post-LT complications in Germany: nationwide study (2005-2018).

Autori: Gu W, Schaaf L, Hortlik H, Zeleke Y, Brol MJ, Schnitzbauer AA, Bechstein WO, Zeuzem S, Queck A, Peiffer KH, Tischendorf M, Pascher A, Laleman W, Praktiknjo M, Schulz MS, Uschner FE, Rennebaum F, Trebicka J
Pubblicato in: European Journal of Gastroenterology & Hepatology, Numero 2023 Nov 1, 2023, Pagina/e 1289-1297, ISSN 0954-691X
Editore: Lippincott Williams & Wilkins Ltd.
DOI: 10.1097/meg.0000000000002640

“Love is a microbe too” : Microbiome dialectics

Autori: Hub Zwart
Pubblicato in: Endeavour, Numero 46, 2022, Pagina/e 100816, ISSN 0160-9327
Editore: Elsevier BV
DOI: 10.1016/j.endeavour.2022.100816

From animal models to gut-on-chip: the challenging journey to capture inter-individual variability in chronic digestive disorders

Autori: Kriaa A, Mariaule V, De Rudder C, Jablaoui A, Sokol H, Wilmes P, Maguin E, Rhimi M.
Pubblicato in: Gut Microbes, Numero 2024 Jan-Dec;16(1):2333434, 2024, ISSN 1949-0984
Editore: Taylor and Francis
DOI: 10.1080/19490976.2024.2333434

Design of a proteolytic module for improved metabolic modeling of Bacteroides caccae.

Autori: Paulay A, Grimaud GM, Caballero R, Laroche B, Leclerc M, Labarthe S, Maguin E
Pubblicato in: mSystems, Numero 2024 Apr 16;9(4):e0015324, 2024, ISSN 0021-9193
Editore: American Society for Microbiology
DOI: 10.1128/msystems.00153-24

The non-selective Rho-kinase inhibitors Y-27632 and Y-33075 decrease contraction but increase migration in murine and human hepatic stellate cells

Autori: Bachtler, Nadine; Torres, Sandra; Ortiz, Cristina; Schierwagen, Robert; Tyc, Olaf; Hieber, Christoph; Berres, Marie-Luise; Meier, Caroline; Kraus, Nico; Zeuzem, Stefan; Nijmeijer, Bart; Pronk, Sebas; Trebicka, Jonel; Klein, Sabine
Pubblicato in: PLoS ONE, Vol 18, Iss 1, p e0270288 (2023), Numero 7, 2023, ISSN 1932-6203
Editore: Public Library of Science
DOI: 10.1371/journal.pone.0270288

Opportunities and barriers for omics-based biomarker discovery in steatotic liver diseases

Autori: Thiele M, Villesen IF, Niu L, Johansen S, Sulek K, Nishijima S, Van Espen L, Keller M, Israelsen M, Suvitaival T, de Zawadzki A, Juel HB, Brol MJ, Stinson SE, Huang Y, Alvarez Silva MC, Kuhn M, Anastasiadou E, Leeming DJ, Karsdal M, Matthijnssens J, Arumugam M, Dalgaard LT, Legido-Quigley C, Mann M, Trebicka J, Bork P, Jensen LJ, Hansen T, Krag A; MicrobLiver and GALAXY consortia; GALAXY consortiu
Pubblicato in: Journal of Hepatology, Numero 2024 Mar 27, 2024, ISSN 0168-8278
Editore: Elsevier BV
DOI: 10.1016/j.jhep.2024.03.035

Beta-blockers in patients with liver cirrhosis: Pragmatism or perfection?

Autori: Sauerbruch T, Hennenberg M, Trebicka J, Schierwagen R
Pubblicato in: Frontiers in Medicine, Numero 2023 Jan 9, 2023, ISSN 2296-858X
Editore: Frontiers Media
DOI: 10.3389/fmed.2022.1100966

Genetic variation in<i>TERT</i>modifies the risk of hepatocellular carcinoma in alcohol-related cirrhosis: results from a genome-wide case-control study

Autori: Buch, Stephan; Innes, Hamish; Lutz, Philipp Ludwig; Nischalke, Hans Dieter; Marquardt, Jens U; Fischer, Janett; Weiss, Karl Heinz; Rosendahl, Jonas; Marot, Astrid; Krawczyk, Marcin; Casper, Markus; Lammert, Frank; Eyer, Florian; Vogel, Arndt; Marhenke, Silke; von Felden, Johann; Sharma, Rohini; Atkinson, Stephen Rahul; McQuillin, Andrew; Nattermann, Jacob; Schafmayer, Clemens; Franke, Andre; Stras
Pubblicato in: Gut, Numero 8, 2023, ISSN 0017-5749
Editore: BMJ Publishing Group
DOI: 10.1136/gutjnl-2022-327196

Personalised human albumin in patients with cirrhosis and ascites: design and rationale for the ALB-TRIAL - a randomised clinical biomarker validation trial.

Autori: Torp N, Israelsen M, Coenraad M, Papp M, Shawcross D, Korenjak M, Angeli P, Laleman W, Juanola A, Gines P, Trebicka J, Krag A; MICROB-PREDICT Consortium.
Pubblicato in: BMJ Open, Numero 2024 Feb 14, 2024, ISSN 2044-6055
Editore: BMJ Publishing Group
DOI: 10.1136/bmjopen-2023-079309

Modeling microbiota-associated human diseases: from minimal models to complex systems

Autori: Doriane Aguanno, Amira Metwaly, Olivia I. Coleman, Dirk Haller
Pubblicato in: Microbiome Research Reports, 2022, ISSN 2771-5965
Editore: OAE Publishing Inc.
DOI: 10.20517/mrr.2022.01

Questioning the fetal microbiome illustrates pitfalls of low-biomass microbial studies

Autori: Kennedy KM, de Goffau MC, Perez-Muñoz ME, Arrieta M-C, Bäckhed F, Bork P, Braun T, Bushman FD, Dore J, de Vos WM, Earl AM, Eisen JA, Elovitz MA, Ganal-Vonarburg SC, Gänzle MG, Garrett WS, Hall LJ, Hornef MW, Huttenhower C, Konnikova L, Lebeer S, Macpherson AJ, Massey RC, McHardy AC, Koren O, Lawley TD, Ley RE, O’Mahony L, O’Toole PW, Pamer EG, Parkhill J, Raes J, Rattei T, Salonen A, Segal
Pubblicato in: Nature, Numero 2023 Jan, 2023, Pagina/e 639-649, ISSN 0028-0836
Editore: Nature Publishing Group
DOI: 10.1038/s41586-022-05546-8

Operating under pressure: Is there a place for preoperative TIPS?

Autori: Praktiknjo M, Trebicka J.
Pubblicato in: JHEP Reports, Numero 2024 Feb 9, 2024, ISSN 2589-5559
Editore: Elsevier B.V.
DOI: 10.1016/j.jhepr.2024.101034

Myostatin is associated with the presence and development of acute-on-chronic liver failure.

Autori: Ruiz-Margáin A, Pohlmann A, Lanzerath S, Langheinrich M, Campos-Murguía A, Román-Calleja BM, Schierwagen R, Klein S, Uschner FE, Brol MJ, Torre-Delgadillo A, Flores-García NC, Praktiknjo M, Macías Rodríguez RU, Trebicka J
Pubblicato in: JHEP Reports, Numero 2023 Apr 14, 2023, ISSN 2589-5559
Editore: Elsevier BV
DOI: 10.1016/j.jhepr.2023.100761

Microbiome risk profiles as biomarkers for inflammatory and metabolic disorders

Autori: Amira Metwaly, Sandra Reitmeier, Dirk Haller
Pubblicato in: Nature Reviews Gastroentrology & Hepatology, 2022, ISSN 1759-5045
Editore: Nature Publishing Group
DOI: 10.1038/s41575-022-00581-2

Risultati finali

Pubblicazioni

Condividi questa pagina

Scarica